2028 To Witness Europe Pharma Packaging Market Hit $35bn
As per a report furnished by Arizton, the pharma packaging and labelling market across Europe is expected to reach $35.78 billion by 2028. This particular segment in Europe, which was valued at $27.04 billion in 2022, is projected to grow at a CAGR of 4.78% until 2028. Europe maintains an important spot in the worldwide pharmaceutical packaging and labelling […]
Vetter Development Service Rankweil successfully completes re-inspection
Vetter’s European clinical site receives permanent Manufacturer’s Authorization Successful inspection completed at clinical site Inspectors were impressed with systems and processes Austrian site supports manufacturing and quality control of Human Investigational Medicinal Products Ravensburg, Germany and Rankweil, Austria, November 9, 2023 – Vetter , a leading global Contract Development and Manufacturing Organization (CDMO), has received […]
Clinerion and Pangaea partner to improve cancer patient lives
Clinerion, provider of the Patient Network Explorer platform which harnesses patient data from a global hospital network, and Pangaea, a machine learning company, partner to improve faster identification of patient cohorts based on phenotypes from electronic health record (EHR) data. Pangaea’s partnership with Clinerion allows it to apply its machine learning algorithms to de-identified patient […]
Understanding HCP Usage of Technology in a Post-Pandemic World through Hidoc
The COVID-19 pandemic has revolutionized the health care system in India by bringing in multiple digital health technologies as the new normal. As a result, our healthcare systems are charting roadmaps to leverage digital tools to design, set up, and implement various telehealth services. HCP or healthcare personnel use the digital concept to keep people […]
Gene Scissors Cramp-Up Viral Infections Within Human Cells
It is still difficult to get to the bottom of viral illnesses. Although isolated medicines exist that block virus multiplication in human cells, they are a significant exception. Against this backdrop, Prof. Reinhard Klein’s from IMC Krems’ Department of Life Sciences’ research group members have now evaluated the potential of molecular technologies so as to […]
Permanent Manufacturer Authorization For Vetter, Rankweil
Vetter, which happens to be a global CDMO, has gone on to receive permanent manufacturer authorization as far as its clinical development site in Rankweil, Austria, is concerned. Functional for almost a couple of years, the responsible national regulatory authority, which in this case is the Austrian Agency for Health and Food Safety- AGES has […]
Indian Pharma Companies Enhanced Global Healthcare Access
As per Indian Government Union Minister Bhagwanth Khuba, Indian pharmaceutical companies have gone on to emerge as dependable and cost-effective options when it comes to high-quality drugs, thereby greatly elevating global access to healthcare. During his speech at the Second World Local Production Forum in The Hague, Khuba stressed the significant role played by India […]
Patient Blood Cells Get Rid of Tumour Through New Therapy
Adoptive cell therapy has gone on to become a promising immunotherapy tool that can be used to help in the treatment of advanced melanoma. The therapy, which makes use of the immune cells that are collected from the individual’s own tumours, can go on to provide new treatment options to cancer patients, thereby potentially bypassing […]
Charles River and Aitia Enter Strategic Agreement to Utilize Logica in Discovery Programs for Neurodegenerative Diseases and Oncology
Charles River Laboratories International, Inc. and Aitia, a leader in the application of Causal AI and Digital Twins announced a strategic agreement that gives Aitia access to Logica™, Charles River’s Artificial Intelligence (AI) powered drug solution platform, for the optimized discovery and early development of multiple therapeutic programs for neurodegenerative disease and oncology. Under the […]
Nona Biosciences Announces Strategic Collaboration with GeneQuantum Healthcare to Empower Early Discovery of Next-Generation Bioconjugates
Nona Biosciences, a global pioneer of technology innovation and antibody discovery and development solutions announced that it has entered into a strategic collaboration with GeneQuantum Healthcare to advance the early discovery of next-generation bioconjugates. Under the terms of the collaboration, Nona Biosciences will integrate GeneQuantum’s exclusive and innovative iLDC (intelligent Ligase-dependent Conjugation) and iGDC (intelligent […]